Latest KFF Health News Stories
Shedding New Light On Hospice Care: No Need To Wait For The ‘Brink Of Death’
Hospice care often prompts fear and misunderstanding, but the services provided can lead to less pain and trauma at the end of life.
Vital Health Officials You’ve Never Heard Of: Insurance Commissioners In The Hot Seat
The fate of the Affordable Care Act’s individual insurance marketplaces remains in play as state insurance commissioners take a central role in the debate.
How Below-The-Radar Mergers Fuel Health Care Monopolies
Most acquisitions by hospitals of physician practices are too small to trigger antitrust attention, study says. But a buying spree of “onesies and twosies” doctor practices has driven competition down and prices up.
Another Way For Anti-Vaxxers To Skip Shots For Schoolkids: A Doctor’s Note
No longer able to get exemptions for personal beliefs in California, parents opposed to inoculations seem to be obtaining medical exemptions for their children, according to a new study.
Rep. Chris Collins’ Australian Stock Bet Looks Bleaker
Innate Immunotherapeutics, the Australian biotech firm whose largest shareholder is Buffalo, N.Y.-area congressman Chris Collins, said it expects to close after its multiple sclerosis drug failed in trials.
St. Kitts Launches Probe Of Herpes Vaccine Tests On U.S. Patients
After a Kaiser Health News report on an offshore herpes vaccine trial that skirted FDA regulations, St. Kitts and Nevis officials claim they had no knowledge of the testing. An investigation is underway.
Pioneering Cancer Gene Therapy Gets Green Light — And $475,000 Price Tag
The USA’s first approved gene therapy — to be used to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment.
Facebook Live: The Prescription Drug Pricing Pipeline
In this Facebook Live, KHN’s Julie Appleby talks with Stephanie Stapleton and answers readers’ questions about the prescription drug pricing pipeline and the industry stakeholders who have a role in what you pay.
En la Clínica Mayo enseñan a controlar el dolor sin opioides
Un programa que ya ha cumplido 40 años ayuda a personas con dolor crónico a mejorar sus vidas sin tomar medicamentos que pueden ser adictivos.
Mayo Pain Expert: Holistic Approach Helps Patients Ditch Opioids
Painkillers were never designed to be used over the long term, says the head of the Mayo Clinic’s pain rehabilitation center. Instead, patients should try other approaches, including relaxation therapies. But getting insurers to cover them might take coaxing.
Polémica por ensayo de una vacuna contra el herpes en el extranjero
El ensayo clínico de una vacuna contra el herpes común fuera de los Estados Unidos ha generado una controversia médica y una investigación gubernamental.
Offshore Human Testing Of Herpes Vaccine Stokes Debate Over U.S. Safety Rules
Prominent businessmen and an American university supported offshore testing of an experimental vaccine.
What Happens If You’re Forced To Switch Health Plans When You’re Sick?
State lawmakers in California have an answer: legislation that would require your new insurer to keep paying for your current doctors even if they’re not in the network.
¿Qué pasa si debes cambiar de plan de salud… estando enfermo?
El retiro de algunas aseguradoras del mercado ha obligado a miles de consumidores a cambiar de plan. Algo que se complica en el caso de pacientes con condiciones crónicas o graves.
Podcast: ‘What The Health?’ Back To Health Crunch Come September
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Margot Sanger-Katz of The New York Times discuss the continuing efforts in Congress to “repeal and replace” the Affordable Care Act, upcoming open enrollment for individual insurance and Congress’ long health care to-do list for September.
Podcast: ‘What The Health?’ Why Is It So Difficult To Control Drug Prices?
In this episode of “What the Health?” Mary Agnes Carey of Kaiser Health News, Sarah Karlin-Smith of Politico, Margot Sanger-Katz of The New York Times and Julie Appleby of Kaiser Health News discuss the recent extension of cost-sharing subsidies for millions of low-income beneficiaries on the Affordable Care Act’s marketplaces and the state of play on Capitol Hill and in the states concerning initiatives to lower prescription drug costs.
Más médicos apoyan un sistema de salud universal
Una nueva encuesta revela que cada vez más los profesionales de la salud se inclinan a un sistema con un pagador único que se haga cargo de las cuentas médicas.
Doctors Warm To Single-Payer Health Care
Growing numbers of physicians say they support a single-payer health care system, a 180-degree turn in opinion over a decade.
CBO: Killing Cost-Sharing Subsidies Would Hike Silver Plan Premiums And Deficit
The change would not be expected to have much long-term effect on the number of uninsured people. But it could cause a shift in which plans are popular with marketplace customers.
Insurers Can Bend Out-Of-Network Rules For Patients Who Need Specific Doctors
Individuals who require very specialized care for their health are advised to make their case when a plan doesn’t cover their doctor.
